Literature DB >> 23021413

Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: a national study.

Monika Pogorzelska1, Patricia W Stone, Elaine L Larson.   

Abstract

BACKGROUND: We performed a survey of National Healthcare Safety Network hospitals in 2008 to describe adoption of screening and infection control policies aimed at multidrug-resistant organisms (MDRO) in intensive care units (ICUs) and identify predictors of their presence, monitoring, and implementation.
METHODS: Four hundred forty-one infection control directors were surveyed using a modified Dillman technique. To explore differences in screening and infection control policies by setting characteristics, bivariate and multivariable logistic regression models were constructed.
RESULTS: In total, 250 hospitals participated (57% response rate). Study ICUs (n = 413) routinely screened for methicillin-resistant Staphylococcus aureus (59%); vancomycin-resistant Enterococcus (22%); multidrug-resistant, gram-negative rods (12%); and Clostridium difficile (11%). Directors reported ICU policies to screen all admissions for any MDRO (40%), screen periodically (27%), utilize presumptive isolation/contact precautions pending a screen (31%), and cohort colonized patients (42%). Several independent predictors of the presence and implementation of different interventions including mandatory reporting and teaching status were identified.
CONCLUSION: This study found wide variation in adoption of MDRO screening and infection control interventions, which may reflect differences in published recommendations or their interpretation. Further research is needed to provide additional insight on effective strategies and how best to promote compliance.
Copyright © 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23021413      PMCID: PMC3652550          DOI: 10.1016/j.ajic.2012.03.014

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  24 in total

1.  Management of inpatients colonized or infected with antimicrobial-resistant bacteria in hospitals in the United States.

Authors:  Rebecca H Sunenshine; Laura A Liedtke; Scott K Fridkin; Larry J Strausbaugh
Journal:  Infect Control Hosp Epidemiol       Date:  2005-02       Impact factor: 3.254

2.  Variation in the use of procedures to monitor antimicrobial resistance in U.S. hospitals.

Authors:  Stephen D Flach; Daniel J Diekema; Jon W Yankey; Bonnie J BootsMiller; Thomas E Vaughn; Erika J Ernst; Marcia M Ward; Bradley N Doebbeling
Journal:  Infect Control Hosp Epidemiol       Date:  2005-01       Impact factor: 3.254

Review 3.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

4.  Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada.

Authors:  Denise Gravel; Michael Gardam; Geoffrey Taylor; Mark Miller; Andrew Simor; Allison McGeer; James Hutchinson; Dorothy Moore; Sharon Kelly; Michael Mulvey
Journal:  Am J Infect Control       Date:  2009-02       Impact factor: 2.918

5.  Public health law for the collection and reporting of health care-associated infections.

Authors:  Benjamin Mason Meier; Patricia W Stone; Kristine M Gebbie
Journal:  Am J Infect Control       Date:  2008-10       Impact factor: 2.918

6.  Structural and process factors affecting the implementation of antimicrobial resistance prevention and control strategies in U.S. hospitals.

Authors:  Ann F Chou; Elizabeth M Yano; Kimberly D McCoy; Deanna R Willis; Bradley N Doebbeling
Journal:  Health Care Manage Rev       Date:  2008 Oct-Dec

Review 7.  Bacterial resistance: a sensitive issue complexity of the challenge and containment strategy in Europe.

Authors:  W T M Jansen; J T van der Bruggen; J Verhoef; A C Fluit
Journal:  Drug Resist Updat       Date:  2006-06-27       Impact factor: 18.500

8.  Estimating health care-associated infections and deaths in U.S. hospitals, 2002.

Authors:  R Monina Klevens; Jonathan R Edwards; Chesley L Richards; Teresa C Horan; Robert P Gaynes; Daniel A Pollock; Denise M Cardo
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

9.  Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes.

Authors:  Jonas Marschall; Denis Agniel; Victoria J Fraser; Joshua Doherty; David K Warren
Journal:  J Antimicrob Chemother       Date:  2008-03-15       Impact factor: 5.790

10.  National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006.

Authors:  William R Jarvis; JoAnn Schlosser; Raymond Y Chinn; Samantha Tweeten; Marguerite Jackson
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

View more
  4 in total

1.  A perspective on how the United States fell behind Northern Europe in the battle against methicillin-resistant Staphylococcus aureus.

Authors:  Kevin T Kavanagh; Daniel M Saman; Yanling Yu
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

Review 2.  Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.

Authors:  Jesús López-Alcalde; Marta Mateos-Mazón; Marcela Guevara; Lucieni O Conterno; Ivan Solà; Sheila Cabir Nunes; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

3.  Modeling risk for developing drug resistant bacterial infections in an MDR-naive critically ill population.

Authors:  Rajiv Sonti; Megan E Conroy; Elena M Welt; Yi Hu; George Luta; Daniel B Jamieson
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

4.  High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting.

Authors:  Abdul Rahman Zaidah; Nurul Izzah Mohammad; Siti Suraiya; Azian Harun
Journal:  Antimicrob Resist Infect Control       Date:  2017-05-02       Impact factor: 4.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.